Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Technology, Dosage Form, Disease, Route of Administration, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Poland, RoE, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The poultry vaccines market majorly consists of the players such Boehringer Ingelheim International GmbH, Zoetis, Inc., Biovac, Phibro Animal Health Corp, Hester Biosciences Ltd, Venky's India Ltd., Dechra Pharmaceuticals Plc, Elanco Animal Health Inc, Merck KgaA, Ceva, Nisseiken Co Ltd, and Vaccinova AB, and amongst others.
The Drinking Water (D/W) segment dominated the global poultry vaccines market and held the largest market share in 2023.
The CAGR value of the poultry vaccines market during the forecasted period of 2023-2031 is 8.6%.
The Avian Influenza segment held the largest share of the market in the global poultry vaccines market and held the largest market share in 2023.
The poultry industry constitutes a significant sector of world agriculture. In the US, more than 8 billion birds are produced annually with a value exceeding US$ 20 billion. Therefore, with rising poultry industry, demand for vaccination is an integral part of flock health management protocols. Therefore, disease prevention is an integral part of flock health management protocols.
Key factors that are driving the growth of this market are rising prevalence of poultry diseases and growing poultry industry are expected to boost the market growth for the poultry vaccines over the years.
Global poultry vaccines market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. Asia Pacific held the largest market share of the poultry vaccines market in 2023.
Zoetis Inc. and Boehringer Ingelheim are the top two companies that hold huge market shares in the poultry vaccines market.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
4. Poultry Vaccines Market Landscape
4.1 PEST Analysis
5. Poultry Vaccines Market – Key Market Dynamics
5.1 Poultry Vaccines Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Poultry Diseases
5.2.2 Growing Poultry Industry
5.3 Market Restraints
5.3.1 Vaccination Failure and Improper Handling
5.4 Market Opportunities
5.4.1 Government Support for Mass Vaccination Drives and Innovative Schemes
5.5 Future Trends
5.5.1 Advancements in Vectored and Combination Vaccines
5.6 Impact of Drivers and Restraints:
6. Poultry Vaccines Market Analysis
6.1 Poultry Vaccines Market Revenue (US$ Million), 2023–2031
7. Poultry Vaccines Market Analysis – by Type
7.1 Overview
7.2 Broiler
7.2.1 Overview
7.2.2 Broiler: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Layer
7.3.1 Overview
7.3.2 Layer: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8. Poultry Vaccines Market Analysis – by Technology
8.1 Overview
8.2 Live Attenuated Vaccines
8.2.1 Overview
8.2.2 Live Attenuated Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Inactivated Vaccines
8.3.1 Overview
8.3.2 Inactivated Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Recombinant Vaccines
8.4.1 Overview
8.4.2 Recombinant Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9. Poultry Vaccines Market Analysis – by Dosage Form
9.1 Overview
9.2 Liquid Vaccines
9.2.1 Overview
9.2.2 Liquid Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Freeze-Dried Vaccines
9.3.1 Overview
9.3.2 Freeze-Dried Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Dust/Powdered Vaccines
9.4.1 Overview
9.4.2 Dust/Powdered Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10. Poultry Vaccines Market Analysis – by Disease
10.1 Overview
10.2 Avian Influenza
10.2.1 Overview
10.2.2 Avian Influenza: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Salmonellosis
10.3.1 Overview
10.3.2 Salmonellosis: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.4 Mareks Disease
10.4.1 Overview
10.4.2 Mareks Disease: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.5 Infectious Bronchitis (IB)
10.5.1 Overview
10.5.2 Infectious Bronchitis (IB): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.6 Infectious Bursal Disease (IBD)
10.6.1 Overview
10.6.2 Infectious Bursal Disease (IBD): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.7 Newcastle Disease
10.7.1 Overview
10.7.2 Newcastle Disease: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.8 Others
10.8.1 Overview
10.8.2 Others: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11. Poultry Vaccines Market Analysis – by Route Of Administration
11.1 Overview
11.2 Drinking Water (D/W)
11.2.1 Overview
11.2.2 Drinking Water (D/W): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11.3 Intramuscular (I/M)
11.3.1 Overview
11.3.2 Intramuscular (I/M): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11.4 Subcutaneous (S/C)
11.4.1 Overview
11.4.2 Subcutaneous (S/C): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12. Poultry Vaccines Market Analysis – by End User
12.1 Overview
12.2 Poultry Farms
12.2.1 Overview
12.2.2 Poultry Farms: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.3 Veterinary Hospitals
12.3.1 Overview
12.3.2 Veterinary Hospitals: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.4 Poultry Vaccination Centers and Clinics
12.4.1 Overview
12.4.2 Poultry Vaccination Centers and Clinics: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13. Poultry Vaccines Market – Geographical Analysis
13.1 North America
13.1.1 North America Poultry Vaccines Market Overview
13.1.2 North America: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.1.3 Poultry Vaccines Market Revenue and Forecast and Analysis – by Country
13.1.3.1 United States: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.1.3.1.1 Overview
13.1.3.1.2 United States: Poultry Vaccines Market Breakdown by Type
13.1.3.1.3 United States: Poultry Vaccines Market Breakdown by Technology
13.1.3.1.4 United States: Poultry Vaccines Market Breakdown by Dosage Form
13.1.3.1.5 United States: Poultry Vaccines Market Breakdown by Disease
13.1.3.1.6 United States: Poultry Vaccines Market Breakdown by Route Of Administration
13.1.3.1.7 United States: Poultry Vaccines Market Breakdown by End User
13.1.3.2 Canada: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.1.3.2.1 Overview
13.1.3.2.2 Canada: Poultry Vaccines Market Breakdown by Type
13.1.3.2.3 Canada: Poultry Vaccines Market Breakdown by Technology
13.1.3.2.4 Canada: Poultry Vaccines Market Breakdown by Dosage Form
13.1.3.2.5 Canada: Poultry Vaccines Market Breakdown by Disease
13.1.3.2.6 Canada: Poultry Vaccines Market Breakdown by Route Of Administration
13.1.3.2.7 Canada: Poultry Vaccines Market Breakdown by End User
13.1.3.3 Mexico: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.1.3.3.1 Overview
13.1.3.3.2 Mexico: Poultry Vaccines Market Breakdown by Type
13.1.3.3.3 Mexico: Poultry Vaccines Market Breakdown by Technology
13.1.3.3.4 Mexico: Poultry Vaccines Market Breakdown by Dosage Form
13.1.3.3.5 Mexico: Poultry Vaccines Market Breakdown by Disease
13.1.3.3.6 Mexico: Poultry Vaccines Market Breakdown by Route Of Administration
13.1.3.3.7 Mexico: Poultry Vaccines Market Breakdown by End User
13.2 Europe
13.2.1 Europe Poultry Vaccine Market Overview
13.2.2 Europe: Poultry Vaccine Market – Revenue and Forecast to 2031 (US$ Million)
13.2.3 Poultry Vaccines Market Breakdown by Countries
13.2.4 Poultry Vaccines Market Revenue and Forecast and Analysis – by Country
13.2.4.1 Germany: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.2.4.1.1 Overview
13.2.4.1.2 Germany: Poultry Vaccines Market Breakdown by Type
13.2.4.1.3 Germany: Poultry Vaccines Market Breakdown by Technology
13.2.4.1.4 Germany: Poultry Vaccines Market Breakdown by Dosage Form
13.2.4.1.5 Germany: Poultry Vaccines Market Breakdown by Disease
13.2.4.1.6 Germany: Poultry Vaccines Market Breakdown by Route Of Administration
13.2.4.1.7 Germany: Poultry Vaccines Market Breakdown by End User
13.2.4.2 Spain: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.2.4.2.1 Overview
13.2.4.2.2 Spain: Poultry Vaccines Market Breakdown by Type
13.2.4.2.3 Spain: Poultry Vaccines Market Breakdown by Technology
13.2.4.2.4 Spain: Poultry Vaccines Market Breakdown by Dosage Form
13.2.4.2.5 Spain: Poultry Vaccines Market Breakdown by Disease
13.2.4.2.6 Spain: Poultry Vaccines Market Breakdown by Route Of Administration
13.2.4.2.7 Spain: Poultry Vaccines Market Breakdown by End User
13.2.4.3 France: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.2.4.3.1 Overview
13.2.4.3.2 France: Poultry Vaccines Market Breakdown by Type
13.2.4.3.3 France: Poultry Vaccines Market Breakdown by Technology
13.2.4.3.4 France: Poultry Vaccines Market Breakdown by Dosage Form
13.2.4.3.5 France: Poultry Vaccines Market Breakdown by Disease
13.2.4.3.6 France: Poultry Vaccines Market Breakdown by Route Of Administration
13.2.4.3.7 France: Poultry Vaccines Market Breakdown by End User
13.2.4.4 United Kingdom: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.2.4.4.1 Overview
13.2.4.4.2 United Kingdom: Poultry Vaccines Market Breakdown by Type
13.2.4.4.3 United Kingdom: Poultry Vaccines Market Breakdown by Technology
13.2.4.4.4 United Kingdom: Poultry Vaccines Market Breakdown by Dosage Form
13.2.4.4.5 United Kingdom: Poultry Vaccines Market Breakdown by Disease
13.2.4.4.6 United Kingdom: Poultry Vaccines Market Breakdown by Route Of Administration
13.2.4.4.7 United Kingdom: Poultry Vaccines Market Breakdown by End User
13.2.4.5 Italy: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.2.4.5.1 Overview
13.2.4.5.2 Italy: Poultry Vaccines Market Breakdown by Type
13.2.4.5.3 Italy: Poultry Vaccines Market Breakdown by Technology
13.2.4.5.4 Italy: Poultry Vaccines Market Breakdown by Dosage Form
13.2.4.5.5 Italy: Poultry Vaccines Market Breakdown by Disease
13.2.4.5.6 Italy: Poultry Vaccines Market Breakdown by Route Of Administration
13.2.4.5.7 Italy: Poultry Vaccines Market Breakdown by End User
13.2.4.6 Rest of Europe: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.2.4.6.1 Overview
13.2.4.6.2 Rest of Europe: Poultry Vaccines Market Breakdown by Type
13.2.4.6.3 Rest of Europe: Poultry Vaccines Market Breakdown by Technology
13.2.4.6.4 Rest of Europe: Poultry Vaccines Market Breakdown by Dosage Form
13.2.4.6.5 Rest of Europe: Poultry Vaccines Market Breakdown by Disease
13.2.4.6.6 Rest of Europe: Poultry Vaccines Market Breakdown by Route Of Administration
13.2.4.6.7 Rest of Europe: Poultry Vaccines Market Breakdown by End User
13.3 Asia Pacific
13.3.1 Asia Pacific Poultry Vaccines Market Overview
13.3.2 Asia Pacific: Poultry Vaccines Market
13.3.3 Poultry Vaccines Market Breakdown by Countries
13.3.3.1 China: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.3.3.1.1 Overview
13.3.3.1.2 China: Poultry Vaccines Market Breakdown by Type
13.3.3.1.3 China: Poultry Vaccines Market Breakdown by Technology
13.3.3.1.4 China: Poultry Vaccines Market Breakdown by Dosage Form
13.3.3.1.5 China: Poultry Vaccines Market Breakdown by Disease
13.3.3.1.6 China: Poultry Vaccines Market Breakdown by Route Of Administration
13.3.3.1.7 China: Poultry Vaccines Market Breakdown by End User
13.3.3.2 India: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.3.3.2.1 Overview
13.3.3.2.2 India: Poultry Vaccines Market Breakdown by Type
13.3.3.2.3 India: Poultry Vaccines Market Breakdown by Technology
13.3.3.2.4 India: Poultry Vaccines Market Breakdown by Dosage Form
13.3.3.2.5 India: Poultry Vaccines Market Breakdown by Disease
13.3.3.2.6 India: Poultry Vaccines Market Breakdown by Route Of Administration
13.3.3.2.7 India: Poultry Vaccines Market Breakdown by End User
13.3.3.3 Japan: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.3.3.3.1 Overview
13.3.3.3.2 Japan: Poultry Vaccines Market Breakdown by Type
13.3.3.3.3 Japan: Poultry Vaccines Market Breakdown by Technology
13.3.3.3.4 Japan: Poultry Vaccines Market Breakdown by Dosage Form
13.3.3.3.5 Japan: Poultry Vaccines Market Breakdown by Disease
13.3.3.3.6 Japan: Poultry Vaccines Market Breakdown by Route Of Administration
13.3.3.3.7 Japan: Poultry Vaccines Market Breakdown by End User
13.3.3.4 Australia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.3.3.4.1 Overview
13.3.3.4.2 Australia: Poultry Vaccines Market Breakdown by Type
13.3.3.4.3 Australia: Poultry Vaccines Market Breakdown by Technology
13.3.3.4.4 Australia: Poultry Vaccines Market Breakdown by Dosage Form
13.3.3.4.5 Australia: Poultry Vaccines Market Breakdown by Disease
13.3.3.4.6 Australia: Poultry Vaccines Market Breakdown by Route Of Administration
13.3.3.4.7 Australia: Poultry Vaccines Market Breakdown by End User
13.3.3.5 South Korea: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.3.3.5.1 Overview
13.3.3.5.2 South Korea: Poultry Vaccines Market Breakdown by Type
13.3.3.5.3 South Korea: Poultry Vaccines Market Breakdown by Technology
13.3.3.5.4 South Korea: Poultry Vaccines Market Breakdown by Dosage Form
13.3.3.5.5 South Korea: Poultry Vaccines Market Breakdown by Disease
13.3.3.5.6 South Korea: Poultry Vaccines Market Breakdown by Route Of Administration
13.3.3.5.7 South Korea: Poultry Vaccines Market Breakdown by End User
13.3.3.6 Rest of APAC: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.3.3.6.1 Overview
13.3.3.6.2 Rest of APAC: Poultry Vaccines Market Breakdown by Type
13.3.3.6.3 Rest of APAC: Poultry Vaccines Market Breakdown by Technology
13.3.3.6.4 Rest of APAC: Poultry Vaccines Market Breakdown by Dosage Form
13.3.3.6.5 Rest of APAC: Poultry Vaccines Market Breakdown by Disease
13.3.3.6.6 Rest of APAC: Poultry Vaccines Market Breakdown by Route Of Administration
13.3.3.6.7 Rest of APAC: Poultry Vaccines Market Breakdown by End User
13.4 Middle East and Africa
13.4.1 Middle East and Africa Poultry Vaccines Market Overview
13.4.2 Middle East and Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.4.3 Poultry Vaccines Market Breakdown by Countries
13.4.4 Poultry Vaccines Market Revenue and Forecast and Analysis – by Country
13.4.4.1 South Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.4.4.1.1 Overview
13.4.4.1.2 The table below represents the H5N8 Avian Influenza (HPAI) outbreak from June 2017 to November 2020:
13.4.4.1.3 South Africa: Poultry Vaccines Market Breakdown by Type
13.4.4.1.4 South Africa: Poultry Vaccines Market Breakdown by Technology
13.4.4.1.5 South Africa: Poultry Vaccines Market Breakdown by Dosage Form
13.4.4.1.6 South Africa: Poultry Vaccines Market Breakdown by Disease
13.4.4.1.7 South Africa: Poultry Vaccines Market Breakdown by Route Of Administration
13.4.4.1.8 South Africa: Poultry Vaccines Market Breakdown by End User
13.4.4.2 Saudi Arabia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.4.4.2.1 Overview
13.4.4.2.2 Saudi Arabia: Poultry Vaccines Market Breakdown by Type
13.4.4.2.3 Saudi Arabia: Poultry Vaccines Market Breakdown by Technology
13.4.4.2.4 Saudi Arabia: Poultry Vaccines Market Breakdown by Dosage Form
13.4.4.2.5 Saudi Arabia: Poultry Vaccines Market Breakdown by Disease
13.4.4.2.6 Saudi Arabia: Poultry Vaccines Market Breakdown by Route Of Administration
13.4.4.2.7 Saudi Arabia: Poultry Vaccines Market Breakdown by End User
13.4.4.3 United Arab Emirates: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.4.4.3.1 Overview
13.4.4.3.2 United Arab Emirates: Poultry Vaccines Market Breakdown by Type
13.4.4.3.3 United Arab Emirates: Poultry Vaccines Market Breakdown by Technology
13.4.4.3.4 United Arab Emirates: Poultry Vaccines Market Breakdown by Dosage Form
13.4.4.3.5 United Arab Emirates: Poultry Vaccines Market Breakdown by Disease
13.4.4.3.6 United Arab Emirates: Poultry Vaccines Market Breakdown by Route Of Administration
13.4.4.3.7 United Arab Emirates: Poultry Vaccines Market Breakdown by End User
13.4.4.4 Rest of Middle East and Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.4.4.4.1 Overview
13.4.4.4.2 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by Type
13.4.4.4.3 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by Technology
13.4.4.4.4 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by Dosage Form
13.4.4.4.5 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by Disease
13.4.4.4.6 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by Route Of Administration
13.4.4.4.7 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by End User
13.5 South and Central America
13.5.1 South and Central America Poultry Vaccines Market Overview
13.5.2 South and Central America: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.5.3 Poultry Vaccines Market Breakdown by Countries
13.5.4 Poultry Vaccines Market Revenue and Forecast and Analysis – by Country
13.5.4.1 Brazil: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.5.4.1.1 Overview
13.5.4.1.2 Brazil: Poultry Vaccines Market Breakdown by Type
13.5.4.1.3 Brazil: Poultry Vaccines Market Breakdown by Technology
13.5.4.1.4 Brazil: Poultry Vaccines Market Breakdown by Dosage Form
13.5.4.1.5 Brazil: Poultry Vaccines Market Breakdown by Disease
13.5.4.1.6 Brazil: Poultry Vaccines Market Breakdown by Route Of Administration
13.5.4.1.7 Brazil: Poultry Vaccines Market Breakdown by End User
13.5.4.2 Argentina: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.5.4.2.1 Overview
13.5.4.2.2 Argentina: Poultry Vaccines Market Breakdown by Type
13.5.4.2.3 Argentina: Poultry Vaccines Market Breakdown by Technology
13.5.4.2.4 Argentina: Poultry Vaccines Market Breakdown by Dosage Form
13.5.4.2.5 Argentina: Poultry Vaccines Market Breakdown by Disease
13.5.4.2.6 Argentina: Poultry Vaccines Market Breakdown by Route Of Administration
13.5.4.2.7 Argentina: Poultry Vaccines Market Breakdown by End User
13.5.4.3 Rest of South and Central America: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.5.4.3.1 Overview
13.5.4.3.2 Rest of South and Central America: Poultry Vaccines Market Breakdown by Type
13.5.4.3.3 Rest of South and Central America: Poultry Vaccines Market Breakdown by Technology
13.5.4.3.4 Rest of South and Central America: Poultry Vaccines Market Breakdown by Dosage Form
13.5.4.3.5 Rest of South and Central America: Poultry Vaccines Market Breakdown by Disease
13.5.4.3.6 Rest of South and Central America: Poultry Vaccines Market Breakdown by Route Of Administration
13.5.4.3.7 Rest of South and Central America: Poultry Vaccines Market Breakdown by End User
14. Industry Landscape
14.1 Overview
14.2 Growth Strategies in the Global Poultry Vaccines Market
14.3 Organic Developments
14.3.1 Overview
14.1 Inorganic Developments
14.1.1 Overview
15. Company Profiles
15.1 Boehringer Ingelheim International GmbH
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 Zoetis Inc
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 BIOVAC
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Phibro Animal Health Corp
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Hester Biosciences Ltd
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Venky's (India) Ltd
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Dechra Pharmaceuticals PLC
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Elanco Animal Health Inc
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Merck KGaA
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Ceva
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
15.11 Nisseiken Co Ltd
15.11.1 Key Facts
15.11.2 Business Description
15.11.3 Products and Services
15.11.4 Financial Overview
15.11.5 SWOT Analysis
15.11.6 Key Developments
15.12 Vaccinova AB
15.12.1 Key Facts
15.12.2 Business Description
15.12.3 Products and Services
15.12.4 Financial Overview
15.12.5 SWOT Analysis
15.12.6 Key Developments
16. Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms
List of Tables
Table 1. Poultry Vaccines Market Segmentation
Table 2. United States: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 3. United States: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 4. United States: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 5. United States: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 6. United States: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 7. United States: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 8. Canada: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 9. Canada: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 10. Canada: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 11. Canada: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 12. Canada: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 13. Canada: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 14. Mexico: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 15. Mexico: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 16. Mexico: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 17. Mexico: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 18. Mexico: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 19. Mexico: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 20. Germany: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 21. Germany: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 22. Germany: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 23. Germany: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 24. Germany: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 25. Germany: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 26. Spain: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 27. Spain: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 28. Spain: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 29. Spain: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 30. Spain: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 31. Spain: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 32. France: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 33. France: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 34. France: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 35. France: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 36. France: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 37. France: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 38. United Kingdom: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 39. United Kingdom: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 40. United Kingdom: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 41. United Kingdom: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 42. United Kingdom: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 43. United Kingdom: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 44. Italy: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 45. Italy: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 46. Italy: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 47. Italy: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 48. Italy: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 49. Italy: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 50. Rest of Europe: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 51. Rest of Europe: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 52. Rest of Europe: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 53. Rest of Europe: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 54. Rest of Europe: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 55. Rest of Europe: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 56. China: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 57. China: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 58. China: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 59. China: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 60. China: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 61. China: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 62. India: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 63. India: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 64. India: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 65. India: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 66. India: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 67. India: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 68. Japan: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 69. Japan: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 70. Japan: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 71. Japan: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 72. Japan: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 73. Japan: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 74. Australia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 75. Australia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 76. Australia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 77. Australia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 78. Australia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 79. Australia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 80. South Korea: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 81. South Korea: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 82. South Korea: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 83. South Korea: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 84. South Korea: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 85. South Korea: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 86. Rest of APAC: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 87. Rest of APAC: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 88. Rest of APAC: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 89. Rest of APAC: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 90. Rest of APAC: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 91. Rest of APAC: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 92. South Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 93. South Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 94. South Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 95. South Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 96. South Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 97. South Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 98. Saudi Arabia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 99. Saudi Arabia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 100. Saudi Arabia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 101. Saudi Arabia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 102. Saudi Arabia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 103. Saudi Arabia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 104. United Arab Emirates: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 105. United Arab Emirates: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 106. United Arab Emirates: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 107. United Arab Emirates: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 108. United Arab Emirates: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 109. United Arab Emirates: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 110. Rest of Middle East and Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 111. Rest of Middle East and Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 112. Rest of Middle East and Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 113. Rest of Middle East and Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 114. Rest of Middle East and Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 115. Rest of Middle East and Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 116. Brazil: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 117. Brazil: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 118. Brazil: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 119. Brazil: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 120. Brazil: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 121. Brazil: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 122. Argentina: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 123. Argentina: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 124. Argentina: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 125. Argentina: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 126. Argentina: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 127. Argentina: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 128. Rest of South and Central America: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 129. Rest of South and Central America: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 130. Rest of South and Central America: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 131. Rest of South and Central America: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 132. Rest of South and Central America: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 133. Rest of South and Central America: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 134. Organic Developments Done by Companies
Table 135. Inorganic Developments Done by Companies
Table 136. Glossary of Terms, Vaccine Adjuvants Market
List of Figures
Figure 1. Poultry Vaccines Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Poultry Vaccines Market Revenue (US$ Million), 2023–2031
Figure 5. Poultry Vaccine Market, By Geography Forecast Analysis, 2023 & 2031
Figure 6. Poultry Vaccines Market Share (%) – by Type, 2023 and 2031
Figure 7. Broiler: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 8. Layer: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 9. Poultry Vaccines Market Share (%) – by Technology, 2023 and 2031
Figure 10. Live Attenuated Vaccines: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 11. Inactivated Vaccines: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 12. Recombinant Vaccines: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 13. Poultry Vaccines Market Share (%) – by Dosage Form, 2023 and 2031
Figure 14. Liquid Vaccines: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 15. Freeze-Dried Vaccines: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 16. Dust/Powdered Vaccines: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 17. Poultry Vaccines Market Share (%) – by Disease, 2023 and 2031
Figure 18. Avian Influenza: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 19. Salmonellosis: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 20. Mareks Disease: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 21. Infectious Bronchitis (IB): Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 22. Infectious Bursal Disease (IBD): Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 23. Newcastle Disease: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 24. Others: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 25. Poultry Vaccines Market Share (%) – by Route Of Administration, 2023 and 2031
Figure 26. Drinking water (D/W): Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 27. Intramuscular (I/M): Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 28. Subcutaneous (S/C): Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 29. Others: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 30. Poultry Vaccines Market Share (%) – by End User, 2023 and 2031
Figure 31. Poultry Farms: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 32. Veterinary Hospitals: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 33. Poultry Vaccination Centers and Clinics: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 34. North America: Poultry Vaccines Market by Key Countries – Revenue (2023) US$ Million
Figure 35. North America: Poultry Vaccines Market – Revenue and Forecast to 2031(US$ Million)
Figure 36. Poultry Vaccines Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 37. United States: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 38. Canada: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 39. Mexico: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 40. Europe: Poultry Vaccine Market – Revenue by Key Countries Revenue 2023 (US$ Million)
Figure 41. Europe: Poultry Vaccine Market – Revenue and Forecast to 2031(US$ Million)
Figure 42. Poultry Vaccines Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 43. Germany: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 44. Spain: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 45. France: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 46. United Kingdom: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 47. Italy: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 48. Rest of Europe: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 49. Asia Pacific: Poultry Vaccines Market – Revenue by Key Countries 2023 (US$ Million)
Figure 50. Asia Pacific: Poultry Vaccine Market – Revenue and Forecast to 2031(US$ Million)
Figure 51. Poultry Vaccines Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 52. China: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 53. India: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 54. Japan: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 55. Australia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 56. South Korea: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 57. Rest of APAC: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 58. Middle East and Africa: Poultry Vaccines Market by Key Countries – Revenue 2023 (US$ Million)
Figure 59. Middle East and Africa: Poultry Vaccine Market – Revenue and Forecast to 2031(US$ Million)
Figure 60. Poultry Vaccines Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 61. South Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 62. Saudi Arabia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 63. United Arab Emirates: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 64. Rest of Middle East and Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 65. South and Central America: Poultry Vaccines Market by Key Countries – Revenue 2023 (US$ Million)
Figure 66. South and Central America: Poultry Vaccines Market – Revenue and Forecast to 2031(US$ Million)
Figure 67. Poultry Vaccines Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 68. Brazil: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 69. Argentina: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 70. Rest of South and Central America: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 71. Growth Strategies in the Global Poultry Vaccines Market
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Get Free Sample For